Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

Annals of Oncology

Volumn 13, Issue 3, 2002, Pages 361-368

  Flamen, P ^a   Van Cutsem, E ^a   Lerut, A ^a   Cambier, J P ^a   Haustermans, K ^a   Bormans, G ^a   De Leyn, P ^a   Van Raemdonck, D ^a   De Wever, W ^a   Ectors, N ^a   Maes, A ^a   Mortelmans, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Induction therapy; Oesophageal cancer; Positron emission tomography; Response assessment; Survival

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION; ADENOCARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS TUMOR; LYMPH NODE; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; REMISSION; RISK FACTOR; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUDEOXYGLUCOSE F 18; HUMAN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REMISSION INDUCTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED;

EID: 0036018910     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf081     Document Type: Article

References (16)

1. Three decades of treatment of oesophageal squamous carcinoma at the Massachusetts General Hospital
2. Concurrent radiation therapy and chemotherapy followed by oesophagectomy for localized oesophageal carcinoma
3. Esophageal cancer
4. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma
5. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus
6. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer
7. Concurrent chemotherapy (CCT), accelerated fractionated radiation (AFR) and surgery for esophageal cancer
8. The utility of positron emission tomography (PET) for the staging of patients with potentially operable esophageal carcinoma
9. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans
10. FDG-PET in esophageal cancer: Incremental value over computed tomography
11. Positron emission tomography for staging of esophageal and gastro-esophageal malignancy
12. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography
13. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
14. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma
15. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients